Stocks Comparison
Abbott Laboratories vs Pfizer: revenue, profit, margins and growth compared
Abbott Laboratories brought in $44.3B of revenue in fiscal 2025, Pfizer $62.6B in fiscal 2025. Revenue changed by +5.7% at Abbott Laboratories and -1.6% at Pfizer on the year before, so Abbott Laboratories grew faster. Abbott Laboratories kept 14.7% of its revenue as net profit, Pfizer 12.4%. Free cash flow was $7.4B at Abbott Laboratories and $9.1B at Pfizer.
Side by side, latest fiscal year
| ABT | PFE | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $44.3B | $62.6B |
| Revenue growth | +5.7% | -1.6% |
| Net income | $6.5B | $7.8B |
| Net margin | 14.7% | 12.4% |
| Free cash flow | $7.4B | $9.1B |
| Free cash flow margin | 16.7% | 14.5% |
| Earnings per share (diluted) | $3.72 | $1.36 |
| Cash | $8.5B | $1.1B |
| Debt | $12.9B | $64.6B |
| Price to earnings | 27.2 | 21.1 |
| Market value | $175.3B | $163.4B |
| Dividend yield | 2.37% | 6.00% |
| Rank by revenue in sector | #18 of 523 · Health care | #13 of 523 · Health care |
Over the years
Questions about Abbott Laboratories and Pfizer
Which is bigger by revenue, Abbott Laboratories or Pfizer?
Pfizer is bigger by revenue: $62.6B in fiscal 2025, against $44.3B for Abbott Laboratories in fiscal 2025.
Which keeps more of its revenue as profit, Abbott Laboratories or Pfizer?
Abbott Laboratories had a net margin of 14.7% in fiscal 2025; Pfizer had 12.4% in fiscal 2025.
Which grew revenue faster, Abbott Laboratories or Pfizer?
In their latest fiscal years revenue changed by +5.7% at Abbott Laboratories and -1.6% at Pfizer.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.